TAIMED BIOLOGICS INC.

 

Area: CDMO

Booth No: M802

Website: http://www.taimedbiologics.com/

 

Exhibitor Profile

 

TaiMed Biologics was formed in 2007 to realize the vision of creating a world-class, innovation-based biotechnology company that will satisfy unmet medical needs. We have vast experience in mAb development and manufacturing and successfully launched the first and only mAb for HIV treatment in US and EU (Trogarzo®).
With our massive expertise, we provide CDMO services including GMP manufacturing, process/ analytical method development, and validation to propel client's commercialization process.

 

Video

 

• 

  Partnering For Innovation

 

 

Exhibit Products

 

• 

  Analysis and Analytical Method Development

• 

  TMB-365

• 

  cGMP Manufacturing

• 

  Formulation Development

• 

  Process Development

• 

  Regulatory Affairs

• 

  TMB-365/TMB-380 (TMB-365 and TMB-380 combination)

• 

  TMB-380 (VRC07-523LS)

 

Exhibitor Press Release

 

• TaiMed’s Long-Acting TMB-365/380 Combination HIV Therapy Receives Taiwan Bio Award 2023-07-25
• TaiMed is Your Reliable Biologics CDMO Service Partner 2023-07-17
• Expedite Your Biologics Development and Manufacturing with TaiMed Biologics. 2023-07-11

 

 

 

back